BSE filing, BSE: 541358. Summary written from the filing by ALFA Finder's alert engine.
Unifinz Capital India Ltd: key numbers
- Share price
- ₹138.00
- Market cap
- ₹610.9 Cr
- Revenue (annual)
- ₹511.6 Cr
- Net profit (annual)
- ₹87.14 Cr
- P/E (TTM)
- 7.8×Sector 19.8×
- Promoter holding
- 19.84%+0.00% QoQ
- FII holding
- 11.29%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Unifinz Capital India Ltd
All →Unifinz Capital India Q2 FY27 Results: Net Profit ₹15.1 Cr, Down 37.1% YoY
Unifinz Capital India Ltd reported revenue from operations of ₹233.7 Cr (+81.0% YoY) and net profit of ₹15.1 Cr (-37.1% YoY) for Q2 FY27.
- Key figure
- Net profit ₹15.1 Cr · -37.1% YoY
Unifinz Capital India Credit Rating
Crisil assigned BBB-/Stable to Unifinz's Rs.100 crore NCDs and reaffirmed ratings on existing debt. Outlook is stable, with the cyber fraud incident not expected to be material.
Unifinz Capital India Convertible Warrants
Unifinz's EGM corrigendum seeks approval for up to 98.01 lakh warrants at ₹102 each, worth ₹99.97 Crore. Vikas Goyal's 11.33 lakh warrants are reallocated to Atika Goyal.
- Value
- ₹99.97 Cr
Unifinz Capital India Board Meeting Date
Unifinz Capital India Ltd will hold a board meeting on 31 October 2026 to consider Q2 and half-year results ended 30 September 2026. The filing is a prior intimation of that future meeting.
Unifinz Capital India Adverse Business Impact
Unifinz Capital reported a second cyber fraud incident, with Rs 7.27 crore paid to third-party accounts on 23 October 2026. The company is investigating and filing complaints with cybercrime authorities.
- Value
- ₹7.27 Cr
Unifinz Capital India Debt & Borrowing: ₹0.44 Cr
Unifinz Capital India made a monthly interest payment of Rs. 0.44 Crore on its non-convertible debentures as per Regulation 57 requirements.
- Value
- ₹0.44 Cr
Other legal & regulatory announcements
All →AstraZeneca Pharma India Legal & Regulatory
Delhi High Court directed NPPA to refrain from coercive steps on Rs.151.20 Crore alleged Symbicort Turbuhaler overcharging. Next hearing is January 11, 2027.
- Value
- ₹151.2 Cr
Jindal Poly Films Legal & Regulatory
Jindal Poly Films disclosed an NCLT petition under Sections 241-242 against Brookfield-linked investor Project Holdings Fourteen over oppression and mismanagement of subsidiary JPL Films. Related arbitration and Delhi High Court proceedings are pending, with financial impact not quantifiable.
Patel Chem Specialities Legal & Regulatory
BSE imposed a ₹0.01 Crore fine on Patel Chem Specialties for perceived LODR Reg 34 non-compliance. The company disputes the penalty, citing an inadvertent filing-year selection error.
- Value
- ₹0.01 Cr
Jyoti Legal & Regulatory
Jyoti Ltd received a rectification order from the Income Tax Department for AY 2020-21. The order levies an income tax demand of Rs.6.82 Crore including interest.
- Value
- ₹6.82 Cr
ICICI Bank Legal & Regulatory
ICICI Bank received an Order in Appeal confirming a GST penalty of Rs.6.95 lakh. The bank will appeal the order within prescribed timelines.
- Value
- ₹0.07 Cr
DIC India Legal & Regulatory
DIC India's GST demand for FY 2021-22 was reduced on appeal to Rs.1.29 lakh from Rs.4.68 lakh. The company is evaluating the order.
- Value
- ₹0.01 Cr